Activity-Based Proteomics
Bioconjugation Chemistry for Single-Atom Signaling and Redox Drug Discovery
We are establishing the area of single-atom signaling, focusing on the study of reversible interconversion of methionine and methionine sulfoxide sites in proteins by adding or removing a single oxygen atom. We develop activity-based proteomics probes to identify new targets of methionine modification as well as writers and erasers that regulate their single-atom biology. These chemical tools also reveal new ligandable hotspots for undruggable protein targets and pathways to accelerate the development of next-generation precision medicines that target redox disease vulnerabilities in cancer and neurodegeneration.
Related Publications
Bioconjugation Methods
-
Oxidative cyclization reagents reveal tryptophan cation–π interactions
-
A Physical Organic Approach to Tuning Reagents for Selective and Stable Methionine Bioconjugation
-
Bioinspired Thiophosphorodichloridate Reagents for Chemoselective Histidine Bioconjugation
-
Redox-based reagents for chemoselective methionine bioconjugation
Single-Atom Signaling
-
Formaldehyde regulates S-adenosylmethionine biosynthesis and one-carbon metabolism
-
Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis
Drug Discovery and Diagnostic Platforms
-
An Activity-Based Oxaziridine Platform for Identifying and Developing Covalent Ligands for Functional Allosteric Methionine Sites: Redox-Dependent Inhibition of Cyclin-Dependent Kinase 4
-
An Activity-Based Methionine Bioconjugation Approach To Developing Proximity-Activated Imaging Reporters